This report from Life Science Intelligence provides the latest market data for the Global Drug Delivery Products Market. Information covered by this report includes:
The global market for drug delivery products was valued at an estimated $15 billion in 2020 and is expected to grow at a CAGR (2020-2024) of 6%. Product segments covered by this report include injection devices, infusion pumps, and related administration sets for drug delivery. Products not covered by this report include oral, depot, and transdermal drug delivery products and implantable pain pumps.
This report covers the impact of COVID-19 on the drug delivery products market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as BD, Baxter, Medtronic, Smiths Medical, and others. The report provides insights into trends, drivers, and limiters of the drug delivery products market, as well as highlights potential opportunities.
The global drug delivery products market was negatively impacted by the COVID-19 pandemic. The pandemic has significantly reduced the number of surgeries and elective hospital visits of patients seeking medical treatment. As a result of this stifling effect, a shortfall in the utilization of drug delivery devices was observed. The market is expected to recover to pre-COVID-19 levels in 2021.
Medtronic, Baxter, and BD are the leading competitors in the global drug delivery products market. Together these three commpanies account for more than 50% of the global market share.